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‘Future n. That period of time in which our affairs
prosper, our friend are true and our happiness is
assured.’
The Devil’s Dictionary, Ambrose Gwinnett Bierce
(1842–1914).
Rhinology
Advances in the treatmentof in￿ammatory sinonasal
disease will follow upon increased understanding of
the molecular biology involved in pathogenesis.
Patients with rhinosinusitis that is allergic in origin
are perhaps most easily described for study and the
allergic process is now well described.
1,2 More
recently cytokine pro￿les have been described for
rhinosinusitis with, and without, polyposis.
3 Pro-
posed mechanisms for polyp formation based upon
cellular interaction, particularly involving the eosi-
nophil have been proposed.
4 Similar cells may also
be important in non-polypoid rhinosinusitis.
5 The
Mayo Clinic group have proposed that eosinophilia
in cases with, and without, polyps is related to fungal
colonization
6 and there is likelyto be a move for the
use of anti-fungal therapy in many cases of chronic
rhinosinusitis.
Understanding of in￿ammation at the cellular and
mediator level creates potential for new therapeutic
agents. Leukotriene pathway modi￿ers are being
used in the treatment of asthma and may have a
place in chronic rhinosinusitis, particularly for
aspirin-sensitive cases but disappointingly a recent
study in patients with seasonal allergic rhinitis failed
to demonstrate any bene￿t.
7 Other mediators are
also potential targets such as antagonists to adhesion
molecules, inter-leukin 5 or immunoglobulin E.
Autoantibodies may also be developed to key
orchestrating cells such as T lymphocytes that are
CD23 positive. New generation anti-histamines with
greater speci￿city, wider anti-in￿ammatory activity
and fewer side-effects may be discovered and
hydrolysable steroids may be engineered that have
no systemic availability.
As the molecular nature of chronic in￿ammatory
airway disease is better understood it is possible that
aetiological gene sequences may be discovered.
Mucin messenger RNA in nasal polyps has recently
been described as having a characteristic pattern,
distinct from normal nasal mucosa.
8 Since the
identi￿cation of the cystic ￿brosis gene, the same
gene has been found in some cases of severe nasal
polyposis unassociated with cystic ￿brosis, although
there is no consistent link.
9 Nasal delivery gene
therapy for cystic ￿brosis has demonstrated correc-
tion of basal nasal potential
10 so the future may see
nasal delivery gene transfer for chronic polypoid
rhinosinusitis.
Nasal delivery of drugs generally is likely to see
further development.
11 Application of topical nasal
corticosteroids may see improved mechanisms for
intranasal distribution of the drug.
12
Some cases ful￿lling the clinical criteria for
‘rhinitis’ may be neurogenic in origin rather than
in￿ammatory. Success with neuropeptide nerve
ablation therapy involving topical application of
capsaicin has been reported
13 which may lead to
the development of tachykinin and neurokinin
antagonists in the treatment of these patients.
Bacterial antibiotic resistance patterns will con-
tinue to evolve and so the choice of antibiotics for
infective rhinosinusitis will be modi￿ed. Viral and
bacterial immunization therapy will also change the
spectrum of pathogens that result in infective
rhinosinusitis. There is a developing trend to
consider bacterial infection less important in the
pathogenesis of chronic rhinosinusitis than was
traditionally the case.
14 The use of antibiotics in
this condition is likely to be re￿ned and should in
future also be less prevalent for acute cases.
15
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techniques will continue to develop and systems that
improve accuracy and safety and that minimize
trauma to normal tissues will be re￿ned. Pre-
operative imaging with software data manipulation
can now provide triplanar views and 3D reconstruc-
tions. These views may act as considerable
perceptional aids to the understanding of involved
anatomy in more dif￿cult cases and morphological
areas such as the frontoethmoidal recess and
pituitary fossa, particularly in revision cases. These
images can also be linked to real-time computer-
aided navigation systems for use during surgery.
16
The debate continuesin relationto the routine use of
facial nerve monitoring during tympanomastoid
surgery and a similar argument will develop regard-
ing endoscopic sinus surgery and routine use of
peri-operative image navigation. The possible
disadvantages of monocular endoscopic vision will
be addressed and the use of 3-D dimensionalsystems
may bring bene￿ts in depth perception as have been
described in laparoscopic surgery.
17 Computed-
assisted surgery should also bring advances that
can be applied to surgical training. Virtual reality
simulation systems of increasing complexity will help
surgeons practise procedures and enable
mesurements of competence (Ota and Loftin,
http://www.vetl.uh.edu/surgery.vrse.html:).
Health purchasers will increasingly require evi-
dence of the level of effectiveness of present and
future treatments. Clinical audits, such as that
currently being carried out by the Royal College of
Surgeons of England on sinonasal surgery, will
demonstrate the results of current practice, for
generic groups of patients, and research, hopefully
conducted through multi-centre trials, will assess the
relative merits of new developments. This should
complement the long-term results on large numbers
of cases of chronic rhinosinusitis who have now been
treated by this approach. It is also likely that the
extended applications of endoscopic surgery such as
ligation of the spheno-palatine artery,
18 dacryo-
crystorhinostomy and orbital decompression will
become routine as their track record is established.
There is certainly an increasing shift towards
endonasal repair of CSF leaks resulting from
congenital dehiscence or trauma to the anterior
skull base. Again this may become a more routine
undertaking with results that rival those of formal
craniotomy and it is likelythat the interface between
our ophthalmic and neurosurgical colleagues will
continue to develop in a very positive way.
Increased understanding of immunopathology and
neurophysiology of sinonasal disease will eventually
enable us to reach the gold standard of accurately
de￿ning disease for individual patients. With this
knowledge individual treatments can be appropri-
ately determined rather than relying on results from
large trials usually involving a heterogenous popula-
tion. As the disease process is better understood
nasal and sinus symptoms such as congestion and
blockage will be better explained. Objective mea-
surements that relate to these symptoms will be
developed and these may then be used to quantify
disease and assess interventions. For example,




Computer-assisted surgery will develop in facial
plastic surgery as in rhinology. Its role is most clearly
seen in craniofacial surgery (Robb and Camp,
http://www.mayo.edu/bir/home.html:). It will ￿nd
applicationin 3-D surface rendering and quantitative
analysis prior to surgery. This enables accurate
planning. Similar analysis after surgery will also
provide data for statistical analysis. 3-D digital
surface photogrammetry, which allows instant
image capture will also be applicable to rhinoplasty.
Computed tomography (CT) image-guided surgery
has now been described in conjunction with facial
skeleton surgery.
20 Facial and pro￿le analysis is the
key stone to successful aesthetic surgery. A surgical
plan based on these analyses relates to a concept of
what constitutes beauty. The future will see changes
in the fashion of beauty as society evolves and
surgical trends will re￿ect these changes.
Biomedical technology will advance. Bioresorb-
able skeletal ￿xation plates will perhaps become
routinely used and current trends have seen the
utilization of alloplastic implant materials with
osteogenic proteins as bone substitutes. The ideal
alloimplant material may eventually be developed
but it is likely to compete with tissue-engineered
cartilage and bone cultured in vivo.
21
Grafts, particularly autogenous cartilage, have
found increasing use in rhinoplasty. This has
particularly followed the increasing application of
open-structure rhinoplasty, where the emphasis is on
reconstruction and re-orientation rather than resec-
tion.
22 We will be in a better position to judge the
long-term aesthetic results of tip grafting. A grad-
uated approach to the use of structural and tip
grafting rather than routine application is already
being advocated. Nasal reconstructive surgery has
improved dramatically over the last decade and the
described techniques should become more available.
Attention is now paid to three layer reconstruction,
including mucosal lining ￿aps, a structural frame-
work and external tissue coverage. Dramatic results
for total nasal reconstruction have been presented.
23
New materials are being developed for the nasal
framework such as vitallium or titanium mesh.
24
Facial reconstruction and rehabilitation will
encompass techniques looking to improve facial
nerve repair. Nerve guidance conduits enriched
with growth factors and Schwann cells are under
investigation as are the effects on regeneration of
local electrical stimulation.
25
The endoscope has seen application in facial
plastic surgery particularly with regard to forehead
lift. Greater experience has now been gained in
midface and orbital complex endoscopic surgery and
the technique may gain increasingly widespread
acceptance.
26
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having a dominant aesthetic component this branch
of surgery will need to develop standard outcome
measures and assessment techniques. This will
enable new procedures and all of us as individual
surgeons to stand up to critical scrunity and
comparison in the future.
Anterior skull base
The surgical ‘gold standard’ for malignant and some
extensive benign tumours affecting the anterior skull
base is likelyto remain the cranio-facialresection for
the foreseeable future.
27 However, the way in which
this is undertaken may change in an effort to avoid
facial scarring. At present this can be done by
combining a bi-coronal and mid-facial degloving
approach but endoscopic resection may be possible
for the intranasal component. It is dif￿cult to see
how an entirely endoscopic approach, as is being
advocated by some European centres, will compare
favourably with the actuarial survival provided by
craniofacial resection for tumours such as olfactory
neuroblastoma and adenocarcinoma given their
natural history. Unfortunately with tumours that
occur relatively infrequently and which may recur
anything up to 15 to 20 years after the original
intervention it will be dif￿cult to make any mean-
ingful comparisons for some time to come. However,
it is possible for benign lesions such as inverted
papilloma to be excised by an experienced endo-
scopic surgeon, even when it involves the skull base
and large series may be accrued in the future to
support this contention.
28
Confucius said: ‘if you would de￿ne the future,
study the past’. It is interesting to re￿ect that many
important advances in understanding nose and sinus
problems were made in the 1890s and that a century
laterwe have seen a second renaissance in rhinology.
It is probably beyond our imagination to predict
what the next hundred years will bring but it seems a
reasonably safe bet that interest in this area will
continueunabated and patients will seek our help for
the foreseeable future.
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